Long-term investors can buy the shares are Jubilant Pharmova (₹545.75) at current levels. The stock made a low of ₹268.60 in March and has risen well from there. It indicates that the downtrend has reversed. This rise from the above mentioned low has happened from a strong long-term trendline support. This also strengthens the case for a trend reversal. Immediate support is at ₹480. Below that ₹350-280 is a broad support zone. Looking at the big picture, Jubilant Pharmova share price can target ₹950-1,050 over the next one-two years. Investors with a minimum time-frame of one year can buy Jubilant Pharmova now. Accumulate on dips at ₹490. Keep a stop-loss at ₹285 initially. Trail the stop-loss up to ₹590 as soon as the stock moves up to ₹780. Move the stop-loss further up to ₹820 when the price touches ₹880. Exit the long positions at ₹950.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.